comparemela.com

Richa Poddar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Agios Appoints Tsveta Milanova as Chief Commercial Officer

CAMBRIDGE, Mass., Dec. 06, 2022 (GLOBE NEWSWIRE) Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering.

Sofiya gradUnited kingdomJessica rennekampTsveta milanovaBrian goffRicha poddarExchange commissionLondon school of economicsCorporate communicationsHarvard advanced management programUniversity of sofiaAgios pharmaceuticals incLondon schoolMedical universityAdvanced managementPrivate securities litigation reform act

Agios strategy shift pays off with FDA approval of first drug for rare anemia

Agios Pharmaceuticals has its third FDA-approved product, and the first under its new rare disease strategy. The regulatory decision also marks the first approved treatment for pyruvate kinase deficiency, a rare disease that leads to chronic anemia.

United kingdomRicha poddarAgios pharmaceuticalsMassachusetts based agiosChief commercial officer richa poddarWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciencesRock healthStartup adviceStartup fundingPatient monitoring system

Agios Appoints Richa Poddar as Chief Commercial Officer

Darrin Miles to Depart Agios to Pursue a Chief Executive Officer Opportunity.

Keck graduate instituteUnited statesUnited kingdomJessi rennekampHolly manningRicha poddarJackie fousePune universityExchange commissionCorporate communicationsAgios pharmaceuticals incDarrin milesClovis oncologyPrivate securities litigation reform actNasdaq agioAgios pharmaceuticals

vimarsana © 2020. All Rights Reserved.